ELI LILLY & Co

4 filings 4 distinct issuers Active 2023-08-14 → 2026-10-16

Track Record

Total filings

2 SCHEDULE 13D · 1 SCHEDULE 13G · 1 SC

Distinct issuers

100% issuer diversity

Median stake

13.6%

3,434,517 avg shares

AI briefs cached

0/4

intent-classified filings

Filed	Form	Issuer	Stake	Shares
2026-10-16	SCHEDULE 13D	TRex Bio, Inc.TRXB	19.90%	5,480,872	view →
2026-07-30	SCHEDULE 13D	Scribe Therapeutics, Inc.SCTX	7.30%	1,388,161	view →
2026-07-24	SCHEDULE 13G	Ionetix Corp / DE /	—	—	view →
2023-08-14	SC	Sigilon Therapeutics, Inc.	—	—	view →

Free. We email you when criteria match. One-click unsubscribe in every email.

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.